Trials Available at Mercyhealth Cancer Care


NRG BR003– A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without  Carboplatin for Node-Positive or High-Risk Node Negative Triple-Negative Invasive Breast Cancer

Alliance A011401 – Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer

Alliance A011502: A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial

Alliance A211601: Evaluation of Mammographic Breast Density Effect of Aspirin: A Companion to Alliance Study A011502

SWOG S1703: Randomized Non-Inferiority Trial Comparing Overall Survival of Patients Monitored with Serum Rumor Marker Directed Disease Monitoring (STMDDM) Versus Usual Care in Patients with Metastatic Hormone Receptor Positive Breast Cancer


Brain/Central Nervous System

No trials currently available.


Colon and Rectum

NRG GI004 – Combination Chemotherapy, Bevacizumab, and/or Atezolizumab in Treating Patients With Deficient DNA Mismatch Repair Metastatic Colorectal Cancer

SWOG S1613 – Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery



No trials currently available.



EA5163/S1709 INSIGNA: A Randomized, Phase III Study of Firstline Immunotherapy alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non?Small Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNature?driven Analysis

LUNGMAP: A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer (Lung-MAP Screening Study)


Mercyhealth Quality of Life Trial

SyMpTOM – Symptom Management Through Oncology Massage


Multiple Myeloma

Lynx – A Pilot Study to Evaluate the Therapeutic Response of Tumor Cells Co-Cultured with Non-tumor Cells from Patients with Multiple Myeloma ex vivo.


Myelodysplastic Syndrome

No trials currently available.



No trials currently available.



No trials currently available.



Alliance A091302 – A Randomised Phase II Study of Sorafenib with or without Everolimus in Patients with Radioactive Iodine Refractory Hürthle Cell Thyroid Cancer


Multiple Cancer Sites

EAY131 – Molecular Analysis for Therapy Choice (MATCH)

UW15068 – UWCCC Precision Medicine Molecular Tumor Board

AMGEN: A Prospective observational Study to Estimate the Incidence of Febrile Neutropenia (FN) Among Subjects With Non-myeloid Malignancies at High Risk for FN and Receiving Neulasta (pegfilgrastim) Onpro Kit or Other Physician Choice Options for Prophylaxis of FN

Exact Sciences/ICONBlood Sample Collection to Evaluate Biomarkers in Subjects with Untreated Solid

Mercyhealth MyChart Sign In